Curing stomach cancer depends on two things done well: removing the tumour with clear margins, and a thorough D2 lymph node dissection — the global standard. Dr. Vinod T. Gore performs robotic and minimally-invasive gastrectomy with meticulous D2 dissection, combined with modern perioperative chemotherapy.
Stomach (gastric) cancer arises from the lining of the stomach, most often as an adenocarcinoma. It can occur anywhere — from the upper stomach near the food pipe to the lower stomach (antrum) near the outlet — and the location influences which operation is needed.
Stomach cancer is often silent early on, with vague indigestion-like symptoms, so many patients are diagnosed late. The good news is that, caught early, it is very treatable — and the cornerstone of cure is a properly performed gastrectomy with a thorough D2 lymph node dissection, usually combined with chemotherapy before and after surgery.
Most cases are linked to Helicobacter pylori infection and to diet, which means a significant proportion of stomach cancer is preventable through treating the infection and improving diet.
Pathologists describe two main patterns (the Lauren classification). They behave differently, which influences the operation and the urgency of clear margins.
Most stomach cancer develops over years from chronic inflammation of the lining. Many of the drivers are preventable or treatable.
Prevention: testing for and treating H. pylori, not smoking, and a diet rich in fresh fruit and vegetables all lower the risk. People with a strong family history or known CDH1 mutation should seek genetic counselling.
Early stomach cancer often feels like ordinary indigestion, which is why it is missed. Persistent symptoms — especially with weight loss, vomiting or anaemia — need an endoscopy.
Staging uses endoscopy with biopsy, endoscopic ultrasound (EUS) for depth, CT and PET-CT, and a staging laparoscopy with peritoneal washings — which is important in stomach cancer to detect hidden spread on the peritoneum.
| Stage | Classification | Description | 5-yr Survival |
|---|---|---|---|
Stage I | T1–T2, N0–N1 | Limited to the inner layers. Very early tumours may be removed endoscopically; others by surgery. | 70–90% |
Stage II | T1–T3, N0–N2 | Deeper invasion or limited node spread. Perioperative chemotherapy with D2 gastrectomy. | 45–60% |
Stage III | T3–T4, N+ | Advanced local disease and/or more nodes. Chemotherapy plus D2 gastrectomy. | 20–40% |
Stage IV | Any T, Any N, M1 | Spread to the peritoneum or distant organs. Systemic therapy; surgery or HIPEC for selected cases. | Variable |
Stomach cancer is treated as a planned sequence — chemotherapy around a properly performed D2 gastrectomy gives the best chance of cure.
The operation removes the part of the stomach containing the cancer, with a clear margin and a thorough D2 node dissection. How much stomach is removed depends on the tumour’s position and pattern — and wherever possible Dr. Gore performs it robotically.
The hardest, most important part of stomach cancer surgery is the D2 lymph node dissection — clearing nodes that hug the major arteries and the delicate surface of the pancreas. This is exactly where robotic surgery helps: the magnified 3D view, wristed instruments and tremor filtration allow precise, controlled dissection in this difficult area, with studies reporting less blood loss, faster recovery and, in some series, fewer pancreas-related complications — while achieving the same lymph node clearance and oncological outcome as open surgery.
Stomach cancer spreads first to the lymph nodes around the stomach and along its arteries. How thoroughly these are removed strongly affects the chance of cure — which is why the ‘D-level’ of dissection matters.
The lymph nodes that must be cleared in stomach cancer sit against the body’s major arteries and the surface of the pancreas — technically the most demanding part of the operation. The control and magnification of robotic surgery are ideally suited to performing this D2 dissection thoroughly and safely.
Modern stomach cancer care rests on strong evidence — for thorough D2 surgery, for chemotherapy around the operation, and for targeted and immune therapies in advanced disease.
References: Dutch D1D2 — Songun I et al., Lancet Oncol 2010;11:439–449. FLOT4 — Al-Batran SE et al., Lancet 2019. CLASSIC — Bang YJ et al., Lancet 2012. ToGA — Bang YJ et al., Lancet 2010. CheckMate 649 — Janjigian YY et al., Lancet 2021. This information is educational and does not replace a personal consultation.
D2 means removing not just the lymph nodes immediately around the stomach (D1) but also those running along the major arteries that supply it. Because stomach cancer spreads to these nodes, a thorough D2 dissection lowers the chance of the cancer coming back. The Dutch trial showed D2 reduces recurrence and gastric-cancer death, which is why it is the world standard.
All three can remove the cancer with a D2 dissection. Robotic surgery offers a magnified 3D view and wristed instruments that are particularly helpful for the delicate node clearance around the pancreas and major arteries — with less blood loss, faster recovery and the same cancer clearance. Open surgery remains appropriate for some very advanced tumours.
Usually, yes, for tumours beyond the earliest stage. The FLOT regimen given before and after surgery improves cure rates. Targeted therapy (for HER2-positive cancers) or immunotherapy may be added in advanced disease.
Not always. For tumours in the lower stomach, only the lower part is removed (distal gastrectomy), preserving the upper stomach. Total gastrectomy — removing the whole stomach — is needed for upper, diffuse or extensive tumours.
You can eat normally again, but in smaller, more frequent meals, especially after a total gastrectomy. A dietitian supports you through the adjustment. After total gastrectomy you will need lifelong vitamin B12 injections, and iron levels are monitored.
Most stomach cancer is linked to long-standing Helicobacter pylori infection and to diet — treating the infection lowers risk. A small proportion is inherited (for example the CDH1 gene causing hereditary diffuse gastric cancer); families with a strong history should seek genetic counselling.
Bring your endoscopy and biopsy report, CT and any PET-CT. Dr. Gore reviews everything personally, coordinates your perioperative plan, and explains the robotic D2 surgical options for your tumour.